These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22113123)

  • 1. Once-daily gabapentin (Gralise) for postherpetic neuralgia.
    Medical Letter
    Med Lett Drugs Ther; 2011 Nov; 53(1378):94. PubMed ID: 22113123
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics, efficacy, and tolerability of a once-daily gastroretentive dosage form of gabapentin for the treatment of postherpetic neuralgia.
    Chen C; Han CH; Sweeney M; Cowles VE
    J Pharm Sci; 2013 Apr; 102(4):1155-64. PubMed ID: 23381946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial.
    Irving G; Jensen M; Cramer M; Wu J; Chiang YK; Tark M; Wallace M
    Clin J Pain; 2009; 25(3):185-92. PubMed ID: 19333167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin for once-daily treatment of post-herpetic neuralgia: a review.
    Beal B; Moeller-Bertram T; Schilling JM; Wallace MS
    Clin Interv Aging; 2012; 7():249-55. PubMed ID: 22866002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intestinal absorption mechanism of gabapentin makes it appropriate for gastroretentive delivery.
    Chen C; Cowles VE; Sweeney M
    Curr Clin Pharmacol; 2013 Feb; 8(1):67-72. PubMed ID: 22946876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over.
    Gupta A; Li S
    Drugs Aging; 2013 Dec; 30(12):999-1008. PubMed ID: 24163280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe postherpetic neuralgia and other neuropathic pain syndromes alleviated by topical gabapentin.
    Hiom S; Patel GK; Newcombe RG; Khot S; Martin C
    Br J Dermatol; 2015 Jul; 173(1):300-2. PubMed ID: 25524254
    [No Abstract]   [Full Text] [Related]  

  • 8. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.
    Wallace MS; Irving G; Cowles VE
    Clin Drug Investig; 2010; 30(11):765-76. PubMed ID: 20818838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of gabapentin and pregabalin for hand surgery patients.
    Brunton LM; Laporte DM
    J Hand Surg Am; 2012 Jul; 37(7):1486-8. PubMed ID: 22721460
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN).
    Sang CN; Sathyanarayana R; Sweeney M;
    Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic pain perspectives: Treating herpes zoster and postherpetic neuralgia: an evidence-based approach.
    Thakur R; Philip AG
    J Fam Pract; 2012 Sep; 61(9 Suppl):S9-15. PubMed ID: 23000670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Rauck RL; Irving GA; Wallace MS; Vanhove GF; Sweeney M
    J Pain Symptom Manage; 2013 Aug; 46(2):219-28. PubMed ID: 23149085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different doses of gabapentin formulations for postherpetic neuralgia: A systematical review and meta-analysis of randomized controlled trials.
    Wang J; Zhu Y
    J Dermatolog Treat; 2017 Feb; 28(1):65-77. PubMed ID: 27798973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study.
    Lee EG; Lee HJ; Hyun DJ; Min K; Kim DH; Yoon MS
    Dermatol Ther; 2016 May; 29(3):184-90. PubMed ID: 26799145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin-induced neurologic toxicities.
    Bookwalter T; Gitlin M
    Pharmacotherapy; 2005 Dec; 25(12):1817-9. PubMed ID: 16305301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world treatment of post-herpetic neuralgia with gabapentin or pregabalin.
    Johnson P; Becker L; Halpern R; Sweeney M
    Clin Drug Investig; 2013 Jan; 33(1):35-44. PubMed ID: 23179473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of pain quality in a clinical trial of gabapentin extended release for postherpetic neuralgia.
    Jensen MP; Chiang YK; Wu J
    Clin J Pain; 2009 May; 25(4):286-92. PubMed ID: 19590476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients.
    Jensen MP; Irving G; Rauck R; Wallace M; Sweeney M; Vanhove GF
    Clin J Pain; 2013 Sep; 29(9):770-4. PubMed ID: 23370075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial.
    Chandra K; Shafiq N; Pandhi P; Gupta S; Malhotra S
    Int J Clin Pharmacol Ther; 2006 Aug; 44(8):358-63. PubMed ID: 16961166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Shingles symptoms are gone but not the pain].
    Urban & Vogel
    MMW Fortschr Med; 2015 Jul; 157(13):35. PubMed ID: 26206026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.